Status:

UNKNOWN

Geriatric Psychiatry and Pharmacovigilance

Lead Sponsor:

Hannover Medical School

Collaborating Sponsors:

Institut für Arzneimittelsicherheit in der Psychiatrie AMSP e.V.

Asklepios Fachklinikum Brandenburg

Conditions:

Dementia

Depression

Eligibility:

All Genders

65+ years

Brief Summary

The purpose of this observational multicenter-study is to investigate safety of psychopharmacological treatment and rates of adverse drug reactions in gerontopsychiatric inpatients. Elderly people are...

Eligibility Criteria

Inclusion

  • Age 65+ years old
  • Inpatients treated at one of the geriatric psychiatry study sites.
  • Signed consent form ( Patient and/or legally authorized custodian)

Exclusion

  • 1\. Patients that are incapable to give their informed consent and are not under legally authorized custodianship.

Key Trial Info

Start Date :

May 1 2013

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2015

Estimated Enrollment :

4000 Patients enrolled

Trial Details

Trial ID

NCT01858857

Start Date

May 1 2013

End Date

December 1 2015

Last Update

May 29 2013

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Krankenhaus Hedwigshöhe

Berlin, Germany

2

Asklepios Fachklinikum Brandenburg

Brandenburg, Germany

3

Hannover Medical School

Hanover, Germany, 30625

4

Asklepios Fachklinikum Lübben

Lubin, Germany

Geriatric Psychiatry and Pharmacovigilance | DecenTrialz